- Home
- UROY vs HUMA Comparison
UROY vs HUMA Comparison
Compare UROY & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UROY
- HUMA
- Stock Information
- Founded
- UROY 2017
- HUMA 2004
- Country
- UROY Canada
- HUMA United States
- Employees
- UROY N/A
- HUMA N/A
- Industry
- UROY
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- UROY
- HUMA Health Care
- Exchange
- UROY Nasdaq
- HUMA Nasdaq
- Market Cap
- UROY 336.8M
- HUMA 367.6M
- IPO Year
- UROY N/A
- HUMA N/A
- Fundamental
- Price
- UROY $2.49
- HUMA $2.32
- Analyst Decision
- UROY Strong Buy
- HUMA Strong Buy
- Analyst Count
- UROY 2
- HUMA 7
- Target Price
- UROY $4.00
- HUMA $13.00
- AVG Volume (30 Days)
- UROY 4.0M
- HUMA 3.2M
- Earning Date
- UROY 07-23-2025
- HUMA 08-12-2025
- Dividend Yield
- UROY N/A
- HUMA N/A
- EPS Growth
- UROY N/A
- HUMA N/A
- EPS
- UROY N/A
- HUMA N/A
- Revenue
- UROY $15,984,827.00
- HUMA $517,000.00
- Revenue This Year
- UROY N/A
- HUMA N/A
- Revenue Next Year
- UROY N/A
- HUMA $896.45
- P/E Ratio
- UROY $435.94
- HUMA N/A
- Revenue Growth
- UROY N/A
- HUMA N/A
- 52 Week Low
- UROY $1.43
- HUMA $1.15
- 52 Week High
- UROY $3.12
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- UROY 58.84
- HUMA 50.18
- Support Level
- UROY $2.38
- HUMA $2.08
- Resistance Level
- UROY $2.54
- HUMA $2.40
- Average True Range (ATR)
- UROY 0.12
- HUMA 0.14
- MACD
- UROY -0.00
- HUMA -0.03
- Stochastic Oscillator
- UROY 73.68
- HUMA 52.63
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.